F Orlandi

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi Galectin-3 is a presurgical marker of human thyroid carcinoma
    F Orlandi
    Department of Clinical and Biological Sciences, University of Turin, Orbassano, Torino, Italy
    Cancer Res 58:3015-20. 1998
  2. ncbi Tubercular involvement of the thyroid gland: a report of two cases
    F Orlandi
    Department of Clinical and Biological Sciences, University of Turin, Italy
    Horm Res 52:291-4. 1999
  3. ncbi Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region
    E Saggiorato
    Section of Endocrinology, Department of Biological and Clinical Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 29:67-73. 2006
  4. ncbi Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma
    E Saggiorato
    Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Clin Endocrinol Metab 86:5152-8. 2001
  5. ncbi Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano TO, Italy
    Endocr Relat Cancer 12:305-17. 2005
  6. doi The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions
    E Raggio
    Esophageal Surgery, General Surgery 3, University of Turin, Turin, Italy
    J Endocrinol Invest 33:378-81. 2010
  7. ncbi Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 27:311-7. 2004
  8. ncbi RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma
    F Orlandi
    Department of Clinical and Biological Sciences, University of Torino, Italy
    J Endocrinol Invest 24:51-5. 2001
  9. ncbi Treatment of medullary thyroid carcinoma: an update
    F Orlandi
    Department of Internal Medicine, S Luigi Hospital, University of Turin, Italy
    Endocr Relat Cancer 8:135-47. 2001
  10. ncbi Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 27:516-22. 2004

Collaborators

Detail Information

Publications13

  1. ncbi Galectin-3 is a presurgical marker of human thyroid carcinoma
    F Orlandi
    Department of Clinical and Biological Sciences, University of Turin, Orbassano, Torino, Italy
    Cancer Res 58:3015-20. 1998
    ..Hence, cytoplasmic galectin-3 staining seems to be a reliable, easy, and cheap marker for presurgical diagnosis of follicular carcinomas and an even more suitable one for papillary carcinomas...
  2. ncbi Tubercular involvement of the thyroid gland: a report of two cases
    F Orlandi
    Department of Clinical and Biological Sciences, University of Turin, Italy
    Horm Res 52:291-4. 1999
    ..Thyroid tuberculosis should be kept in mind in the differential diagnosis of thyroid nodules, notably in patients with a history of tuberculous disease. FNAb represents the main approach to making the diagnosis...
  3. ncbi Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region
    E Saggiorato
    Section of Endocrinology, Department of Biological and Clinical Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 29:67-73. 2006
    ..Despite a sufficient median urinary iodine excretion, a program of iodine prophylaxis is strongly recommended due to a large part of iodine-deficient population...
  4. ncbi Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma
    E Saggiorato
    Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Clin Endocrinol Metab 86:5152-8. 2001
    ..It also proves to be useful in the histopathological assessment of resected tumors having suspected malignant features...
  5. ncbi Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano TO, Italy
    Endocr Relat Cancer 12:305-17. 2005
    ..The combination of three or more markers did not substantially improve the diagnostic accuracy of the test...
  6. doi The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions
    E Raggio
    Esophageal Surgery, General Surgery 3, University of Turin, Turin, Italy
    J Endocrinol Invest 33:378-81. 2010
    ..Aim of the study was to consider the diagnostic accuracy of galectine-3 (GAL3) in the pre-operative cytological evaluation of follicular lesions...
  7. ncbi Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 27:311-7. 2004
    ..The routine correct use of galectin-3, by increasing the diagnostic accuracy of conventional cytology, improves the management of thyroid nodules and can lead to a sensitive reduction of useless thyroid surgeries...
  8. ncbi RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma
    F Orlandi
    Department of Clinical and Biological Sciences, University of Torino, Italy
    J Endocrinol Invest 24:51-5. 2001
    ..Our findings suggest that constitutive RET proto-oncogene activation may be involved in the development of mixed medullary-follicular thyroid carcinoma...
  9. ncbi Treatment of medullary thyroid carcinoma: an update
    F Orlandi
    Department of Internal Medicine, S Luigi Hospital, University of Turin, Italy
    Endocr Relat Cancer 8:135-47. 2001
    ..The role of surgery, external radiotherapy, radionuclide therapy and medical treatment, including biological response modifiers and cytotoxic drugs, are reviewed and discussed...
  10. ncbi Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area
    E Saggiorato
    Section of Endocrinology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 27:516-22. 2004
    ..Despite a sufficient median urinary iodine excretion, a focused program of iodine prophylaxis should be developed due to the presence of a large rate of iodine-deficient population...
  11. doi Motesanib diphosphate in progressive differentiated thyroid cancer
    Steven I Sherman
    Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M D Anderson Cancer Center, Houston 77230 1402, USA
    N Engl J Med 359:31-42. 2008
    ..Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT...
  12. ncbi Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor
    R M Ruggeri
    Section of Endocrinology, Clinical Experimental Department of Medicine and Pharmacology, University of Messina School of Medicine, Messina, Italy
    J Endocrinol Invest 25:959-66. 2002
    ..In the normal thyroid tissue, colloid nodules, and another subset of benign and malignant thyroid nodules, IL-6 expression is under control of signals other than CD30L/CD30...
  13. ncbi Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA
    F Porpiglia
    Divisione di Urologia, Dipartimento di Scienze Cliniche e Biologiche, Universita degli Studi di Torino, Italia
    Horm Res 57:197-9. 2002
    ..Moreover, the preservation of a portion of the adrenal cortex may prevent the need for a life-long steroid replacement therapy...